Iron deficiency anaemia can be improved after eradication of Helicobacter pylori

Postgraduate Medical Journal

Volumn 86, Issue 1015, 2010, Pages 272-278

  Huang, Xiaolu ^a,b   Qu, Xinhua ^a,b   Yan, Weili ^a,b   Huang, Youliang ^c   Cai, Mingci ^b   Hu, Bing ^b   Wu, Lianming ^b   Lin, Hai ^d   Chen, Zhiwei ^b   Zhu, Cuiying ^a,b   Lu, Ngen ^b,e   Sun, Xu ^f,g   Rong, Lan ^f,g   Jiang, Yibin ^f,g   Sun, Dayu ^f,g   Zhong, Liang ^f,g   Xiong, Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Shanghai Health Development Research Center   (China)

^e Shanghai Institute of Digestive Disease   (China)

^f FUDAN UNIVERSITY   (China)

^g FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; FERRITIN; HEMOGLOBIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TINIDAZOLE;

ARTICLE; ASIA; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; ERADICATION THERAPY; FERRITIN BLOOD LEVEL; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; IRON DEFICIENCY ANEMIA; META ANALYSIS; PRACTICE GUIDELINE; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; ANEMIA, IRON-DEFICIENCY; ANTI-BACTERIAL AGENTS; BISMUTH; CHILD; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953711091     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.089987     Document Type: Article

References (40)

1. World Health Organization. World prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. World Health Organization. http://whqlibdoc.who.int/ publications/2008/9789241596657-eng.pdf, (accessed 2008).
2. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370:511-20. (PMID: 17693180), doi: 10.1016/S0140-6736(07)61235-5.
3. World Health Organization. Control of iron deficiency anaemia in South-East Asia. Report of an intercountry workshop. http://whqlibdoc.who.int/ searo/1994-99/SEA-NUT-134.pdf (accessed 1995).
4. World Health Organization, United Nations University, The United Nations Children's Fund. Iron deficiency anaemia. Assessment, prevention and control: A guide for programme managers. http://whqlibdoc.who.int/hq/2001/WHO-NHD-01.3.pdf (accessed 2001).
5. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81 (PMID: 17170018), doi: 10.1136/gut.2006.101634.
6. DuBois S, Kearney DJ. Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol 2005;100:453-9 (PMID: 15667507), doi: 10.1111/j.1572-0241.2005.30252.x.
7. Annibale B, Marignani M, Monarca B, et al. Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med 1999;131:668-72 (PMID:10577329).
8. Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007;102:1808-25. (PMID:17608775), doi: 10.1111/j.1572-0241.2007.01393.x.
9. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107:224-33 (PMID: 3300460).
10. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of metaanalyses of randomised controlled trials: the QUOROM statement. Quality reporting of Meta-Analyses. Lancet 1999;354:1896-900. (PMID: 10584742), doi: 10.1016/S0140-6736(99)04149-5.
11. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (PMID: 8721797), doi: 10.1016/0197-2456(95)00134-4.
12. Kunz AR, Oxman AR. Empirical evidence of selection bias in studies of the effects of health care: a systematic review. Presented at the Cochrane Colloquium, Oslo, 1995.
13. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. JAMA 1995;273: 408-12 (PMid:7823387), doi: 10.1001/jama.273.5.408.
14. Karlowski TR, Chalmers TC, Frenkel LD, et al. Ascorbic Acid for common cold: a prophylactic and therapeutic trail. JAMA 1975;231:1038-42 (PMid:163386), doi: 10.1001/jama.231.10.1038.
15. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in camparisons of therapy. I: medical. Star Med 1989;8:441-54 (PMid:2727468), doi: 10.1002/sim.4780080408.
16. Follmann D, Elliott P, Suh I, et al. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992;45:769-73 (PMID: 1619456), doi: 10.1016/0895-4356(92)90054-Q.
17. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219 (PMid:12543843), doi: 10.1136/bmj.326.7382.219.
18. Higgins JPT,Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration2008 http://www.cochrane.org/resources/handbook.
19. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in STATA™. In: Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. London: BMJ Publishing, 2001;347-69.doi: 10.1002/9780470693926.ch18.
20. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29. doi: 10.2307/3001666.
21. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in metaanalyses. BMJ 2003;327:557-60. (PMid:12958120), doi: 10.1136/bmj.327.7414. 557.
22. DerSimonian R, Laird N. Meta analysis in clinical trials. Controlled Clin Trials 1986;7:177-88 (PMid:3802833), doi: 10.1016/0197-2456(86)90046-2.
23. Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol 1999;150: 469-75 (PMID: 1672966).
24. Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34 (PMid:9310563).
25. Choe YH, Kim SK, Son BK, et al. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter 1999;4:135-9 (PMid:10382128), doi: 10.1046/j.1523-5378.1999.98066.x.
26. Huang LP, Zhuang ML, Bei GP. Clinical treatment study of iron deficiency anemia associated Helicobacter pylori infection. J appal clin ediatr. 2005;20:30-1 (in chinese).
27. Lin Y, Wang WG, Wang SZ. Treatment of iron-deficiency anemia in patients with concomitant Helicobacter pylori infection:experience of 68 cases. Chin J Contemp Pediatr. 2005;7:429-31 (in chinese).
28. Chen LH, Luo HS. Clinical study on Helicobacter pylori influence therapeutics of Iron deliciency anemia in adults. Chin J Mod Med.2005; 15: 2969-71 (in chinese).
29. Ren B. Study on relationship between iron deficiency anemia and Helicobacter pylori infection. J Clin Re 2006;11:1805-6 (in chinese).
30. Chen LH, Luo HS. Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori -positive chronic gastristis. World J Gastroenterol 2007;13:5380-3 (PMid:17879411).
31. Vijayan G, Sundaram RC, Bobby Z, et al.Increased plasma malondialdehyde and fructosamine in anemic H pylori infected patients: effect of treatment. World J Gastroenterol 2007;13:796-800 (PMid:17278206). (Pubitemid 46252404)
32. Sarker SA, Mahmud H, Davidsson L, et al. Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children. Gastroenterology 2008;135:1534-42 (PMid:18775429), doi: 10.1053/j.gastro.2008.07.030.
33. Michael Dobson. World health organization hemoglobin color scale, a practical answer to a vital need. Update in Anaesthesia 2002;6/1-6/2.
34. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008;13:323-40 (PMid:19250507), doi: 10.1111/j.1523-5378.2008.00617.x.
35. Hutchinson C, Geissler CA, Powell JJ, et al. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 2007;56:1291-5 (PMid:17344278), doi: 10.1136/gut.2006.108613.
36. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600 (PMid:19788600), doi: 10.1111/j.1440-1746.2009.05982.x.
37. Huang JQ, Sridhar S. Role of Helicobacter pylori infection and non-steroidal antiinflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22 (PMID: 11809181), doi: 10.1016/S0140-6736(02)07273-2. (Pubitemid 34119190)
38. Jolobe O. Guidelines for the management of iron deficiency anaemia. Gut 2001;48:283-4 (PMID: 11211859), doi: 10.1136/gut.48.2.283b.
39. World Health Organization, Food and Agricultural Organization of the United Nations. Vitamin and mineral requirements in human nutrition. http://whqlibdoc.who.int/publications/2004/9241546123.pdf (accessed 2004).
40. Dallman PR, Siimes MA, Stekel A. Iron deficiency in infancy and childhood. Am J Clin Nutr 1980;33:86-118 (PMID 6986756).